Related Experiment Videos

Patterns and predictors of statin use after coronary artery bypass graft surgery

Alexander Kulik1, Raisa Levin, Marc Ruel

  • 1Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada.

The Journal of Thoracic and Cardiovascular Surgery
|October 2, 2007
PubMed

Insights

Statin prescription rates after coronary artery bypass graft surgery remain low, despite increasing trends. Quality improvement initiatives are needed to ensure this at-risk population receives appropriate statin therapy.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Health Services Research

Background:

  • Statin therapy is proven to benefit patients with coronary artery disease, including those post-coronary artery bypass graft (CABG) surgery.
  • Postoperative statin use following CABG surgery is crucial for secondary prevention of cardiovascular events.

Purpose of the Study:

  • To evaluate statin prescription rates in patients after undergoing CABG surgery.
  • To identify factors influencing the administration of statins in the postoperative period.

Main Methods:

  • A retrospective cohort study analyzed 9284 Medicare patients aged 65+ who underwent CABG surgery between 1995 and 2004.
  • Linked hospital and pharmacy claims data were used to calculate statin use rates and identify predictors via generalized estimating equations.

Main Results:

  • Only 35.9% of patients received statins within 90 days of discharge, though rates improved from 13.1% in 1995 to 60.9% in 2004.
  • Preoperative statin use, later surgical year, and more postoperative medications were associated with increased statin use.
  • Peripheral vascular disease, diabetes, stroke, and older age were associated with decreased postoperative statin use.

Conclusions:

  • Statins are significantly underutilized in patients post-CABG surgery, indicating a gap in care.
  • Despite increasing trends, current statin use patterns do not align with coronary artery disease risk factors.
  • Targeted quality improvement interventions are necessary to enhance statin administration in this high-risk population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...